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Objective: Airway mucins may play an important role in the mechanism of respi-
ratory complications after cardiopulmonary bypass in infants and children. Our aim
was to measure airway mucin levels before and after cardiopulmonary bypass and
to determine whether changes in mucin levels were associated with the development
of respiratory complications.
Methods: Airway glycoprotein and mucins (MUC5AC, MUC5B, and MUC2) in
serial small-volume airway lavage samples from 39 young children who underwent
cardiac operations with cardiopulmonary bypass were measured by slot-blot assay with
specific antimucin peptide antibodies. The relationship between mucin changes and
post–cardiopulmonary bypass respiratory complications was investigated. Airway la-
vage samples were also collected from 11 children before and after operation without
cardiopulmonary bypass, and changes in mucin levels were compared with those in
subjects who underwent cardiopulmonary bypass. Airway lavage sample DNA was also
measured to investigate the relationship between mucin changes and lung injury.
Results: Glycoprotein, MUC5AC, and MUC5B levels were significantly increased
after cardiopulmonary bypass (P  .001) whereas MUC2 level was not. Children
with respiratory complications showed significantly higher glycoprotein and
MUC5AC levels than did children without respiratory complications before and
after cardiopulmonary bypass (P  .05). Increase of total mucin (MUC5AC,
MUC5B, and MUC2) during cardiopulmonary bypass showed positive correlation
with DNA increase during cardiopulmonary bypass (r 0.73), PaCO2 (r 0.62) and
alveolar-arterial oxygen difference (r  0.55) immediately after cardiopulmonary
bypass. Increase of total mucin was associated with postoperative respiratory
complications and their severity. There were no significant changes detected in
airway mucin during operations without cardiopulmonary bypass.
Conclusions: Airway mucins were increased during cardiopulmonary bypass, and
this increase was associated with markers of lung injury after cardiopulmonary
bypass and with the development of postoperative respiratory complications.
Respiratory complications are common in pediatric cardiac sur-gery,1-2 but the mechanisms for such respiratory problems remainpoorly understood. Abnormalities include gas exchange failure,hypersecretion, and pulmonary atelectasis, and these are sometimesassociated with more serious complications, such as critical hypox-emia, pneumonia, and death.3,4
Mucins are key components of the mucosal defensive barrier and the host’s
ability to resist lung injury. The main secreted gel-forming mucins present in the
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respiratory tract are MUC5AC, in superficial mucosa, and
MUC5B, in the submucosal glands.5-7 In normal airways,
mucins cover the epithelial surface of the respiratory
tract, and mucin production is maintained at a relatively
low level. In pathologic conditions such as asthma, bron-
chitis, and acute respiratory distress syndrome, however,
mucin accumulates in the respiratory tract and impairs
gas exchange. Bacterial colonization may then lead to
infection and lung damage.5-7 The study of mucins has
relied largely on measurement of gene expression by mes-
senger RNA, giving an indirect assessment of the translated
gene product. However, the development of specific antimucin
peptide antibodies has now allowed measurement of translated
mucin gene products5,7.
This study focused on airway mucin and its role in the
mechanism of respiratory complication of pediatric car-
diac surgery. We hypothesized that mucin synthesis and
secretion was increased in the airway during cardiopul-
monary bypass (CPB) and that this increase would be
associated with respiratory complications, such as lung
collapse and pneumonia. The relationship between mucin




Thirty-nine infants and children undergoing cardiac surgery
with CPB at Bristol Children’s Hospital were prospectively
recruited for the study. The characteristics of the study popu-
lation are shown in Table 1. Eleven patients who underwent
cardiac operations without CPB during the same period were
also recruited for comparison. Excluded were children under-
going emergency cardiac surgery, any patient who had mechan-
ical ventilation before operation, and children with a history of
recent respiratory tract infection or other infectious diseases
before the operation. No patients with heart disease as a com-
ponent of a congenital syndrome were included in this study.
The study was approved by the local research ethics committee,
and informed, written consent was obtained from the parents of
all children in the study.
Operations and Ventilator Conditions
All the operations with CPB were performed through a median
sternotomy, whereas all the operations without CPB were per-
formed through a right or left thoracotomy. Cardiac repairs with
CPB were done under total CPB with ascending aortic and bicaval
cannulations and cardiac arrest. Anesthesia followed a standard
protocol with fentanyl and isoflurane. All patients undergoing CPB
received 10 mg/kg methylprednisolone.
TABLE 1. Clinical data of study subjects
No respiratory complication Respiratory complication No CPB
Subjects (No.) 25 14 11
Age (mo, median and interquartile range) 14.0 (2.5-48.0) 12.5 (6.0-36.0) 17.0 (3.5-68.8)
Body weight (kg, median and interquartile range) 7.4 (4.0-15.9) 7.8 (4.5-11.5) 10.6 (5.8-15.2)
Cyanosis (No.)
No 15 6 6
Yes 10 8 5
Pulmonary flow (No.)
Increased 15 8 4
Normal 6 1 2
Decreased 4 5 5
Operations (No.)
Ventricular septal defect repair 5 2
Atrial septal defect* repair 4 3
Tetralogy of Fallot repair 4 4
Arterial switch 3 2
Valve surgery 4
Patent ductus arteriosus ligation 3
Coactation repair 2
Coactation repair and pulmonary artery banding 1
Blalock-Taussig shunt 5
Others 5 3
CPB time (min, median and interquartile range) 52.0 (40.1-81.0) 66.5 (51.0-109.0) Not applicable
Lowest rectal temperature (°C, median and interquartile range) 28.1 (22.1-32.0) 27.7 (24.0-28.0) Not available
Lowest hemoglobin (g/dL, median and interquartile range) 8.1 (7.3-9.4) 7.6 (6.9-8.2) Not available
Ventilation time (h, median and interquartile range) 11.0 (5.0-24.0) 24.0 (7.0-80.0) 16.0 (1.8-23.6)
No significant differences were seen between the three groups in each parameter.
*Including partial atrioventricular septal defect.
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Ventilator (pressure control) settings were determined by anes-
thetists to obtain favorable PaCO2 (35.0-40.0 mm Hg) and pH
(7.35-7.45) before CPB. Mechanical ventilation was discontinued
during CPB, and the lungs were not ventilated until weaning from
CPB. To investigate the increase in PaCO2 during CPB, ventilator
settings were unchanged (from before CPB) until the result of the
first blood gas analysis was available after CPB, although inspired
oxygen fraction was increased to 1.0 in all cases.
Postoperative Management and Clinical Outcomes
Intensive care physicians who were not involved in the study
managed postoperative treatment, including ventilator settings.
Respiratory complications were diagnosed by intensive care phy-
sicians and classified by us into four categories according to
previously agreed clinical criteria: grade 0, no respiratory compli-
cation; grade 1, significant sputum production, for which physio-
therapy including bronchial irrigation was frequently required;
grade 2, evidence of lung collapse on chest radiograph in associ-
ation with sputum production; and grade 3, pneumonia diagnosed
on the basis of clinical, radiologic, and bacteriologic findings.
Blood gas analysis was done before CPB, immediately after
CPB, and at 1, 4, and 24 hours after CPB as long as an arterial line
was in situ. Alveolar arterial oxygen difference (PAO2 PaO2) was
calculated, except in patients with right-to-left shunts.
Airway Lavage Procedure and Preparation of Samples
Small-volume airway lavage (1 mL/kg body weight) fluid samples
were collected by a previously described nonbronchoscopic meth-
od.8,9 All samples were taken under conditions of general anes-
thesia, including muscle relaxation. Collection of airway lavage
fluid was carried out four times for children undergoing CPB: (1)
before the operation, (2) immediately before stopping CPB and
restarting mechanical ventilation, (3) 4 hours after CPB ended, and
(4) 24 hours after CPB ended. Airway lavage samples were also
collected from children not undergoing CPB before and immedi-
ately after the operation. To stabilize mucin in lavage samples, an
equal volume of guanidine buffer with inhibitors was added to the
airway lavage sample. The samples were stored at 4°C.
Measurement of Protein and DNA in Airway Lavage
Fluid
Protein concentration in airway lavage fluid was measured with the
Bradford dye-binding technique.10 DNA concentration was mea-
sured with a fluorimetric dye-binding assay as previously de-
scribed elsewhere.11
Analysis of Mucins in Airway Lavage Fluid
The relative concentrations of the mucins MUC2, MUC5AC, and
MUC5B5,7,13 were determined from slot blots14 and calibrated
relative to purified major bovine submaxillary gland mucin12 as a
reference standard. The amount of glycoprotein (largely mucin)
was detected in the lavage samples with wheat germ agglutinin–
horseradish peroxidase conjugate (Vector Labs, Peterborough,
UK) and calibrated with major bovine submaxillary gland mucin
before measurement with specific antimucin antisera. All unknown
samples were measured on the same blot membrane as the major
bovine submaxillary gland mucin standards to eliminate reagent
and membrane artifacts. According to the value of glycoprotein
determined with wheat germ agglutinin, equivalent amounts of the
lavage samples were applied to polyvinylidine fluoride membranes
(Millipore, Watford, UK) and tested for reactivity with each of the
antimucin antibodies. The monoclonal antibody NCL-HGM-45M1
(Novocastra Laboratories Ltd, Newcastle upon Tyne, UK) was
used for MUC5AC at 1:1600; polyclonal antibody M5B was used
for MUC5B7 (1:2000), and polyclonal antibody LUM2-3 was used
for MUC213 (1:2000). Detection was as described before, and the
blots were scanned with a Hewlett-Packard HP2C scanner
(Hewlett-Packard Ltd, Bracknell, UK). Their intensity was mea-
sured densitometrically with Optimas Bioscan Software (Bioscan,
Inc, Washington, DC).
Calibration curves were determined with standard preparations
containing MUC5AC and MUC5B, isolated from human respira-
tory tract lavage samples purified by density-gradient centrifuga-
tion,7,13,14 and a MUC2 standard generated by glutaraldehyde
cross-linking of the LUM2-3 immunizing peptide
NGLQPVRVEDPDGC (MWG Biotech), with bovine serum albu-
min and purification by Sephadex G25 chromatography (Amer-
sham Pharmacia Biotech AB, Uppsala, Sweden).15. The optical
densities of slot blots for unknown lavage samples with each
antimucin antibody were measured within the linear range of the
calibration curve for the standards. The mucin content of each
lavage sample was calculated as micrograms of mucin (MUC5AC/
MUC5B) and micrograms of MUC2 peptide–bovine serum albu-
min equivalent. The sum of MUC5AC, MUC5B, and MUC2
values was calculated as total mucins, and the ratio MUC5AC to
total mucins was the MUC5AC ratio.
Data Expression and Statistical Analyses
Mucin and glycoprotein concentrations in airway lavage fluid were
calculated as micrograms per microgram of protein, and DNA
concentrations were calculated as nanograms per microgram of
protein. Data in the text and table are expressed as median and
interquartile range. Changes in mucin and DNA concentrations
after CPB were calculated by subtraction of the pre-CPB value
from the immediate post-CPB value.
All statistical analyses were performed with SPSS 11.0J for
Windows (SPSS Inc, Chicago, Ill). Because most of the data were
not normally distributed, nonparametric tests were used for all
analyses. Differences between two groups were evaluated with the
Mann-Whitney U test. When three or more groups were compared,
the Kruskal-Wallis test was applied before Mann-Whitney U test,
and if the P value thus obtained was less than .05, the Bonferroni
correction was applied. To investigate the differences between
preoperative values and measurements at different time points
within each group, the Friedman test was performed initially; and
if the P value was less than .05, the Wilcoxon test and the
Bonferroni correction were applied to identify the significant dif-
ferences. The Spearman test was used to investigate the correlation
between any mucin values and preoperative and intraoperative
factors or grades of lung injury.
Results
All 50 patients had satisfactory cardiac function on postop-
erative echocardiographic analysis. Airway lavage fluid
samples were available for all children before and after CPB
or operation, but the number of samples decreased to 33 (22
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without and 11 with respiratory complications) and 15 (7
without and 8 with respiratory complications) at 4 and 24
hours after CPB, respectively, because of the cessation of
assisted ventilation. Respiratory complications of grades 1,
2, and 3 were detected in 3, 7, and 4 patients, respectively.
Mucin and Glycoprotein Changes During and After
CPB
Protein concentrations in sequential lavage samples were
relatively constant (before CPB 0.34 g/L, interquartile
range 0.18-0.79 g/L, after CPB 0.35 g/L, interquartile
range 0.21-0.67 g/L, 4 hours 0.40 g/L, interquartile
range 0.20-0.67 g/L, 24 hours 0.29 g/L, interquartile
range 0.17-0.79 g/L). Glycoprotein showed significant
increase during CPB in the respiratory complication group.
There were significant increases in MUC5AC and MUC5B
concentrations but not in MUC2 after CPB in patients both
with and without respiratory complications (Figure 1). At
all time points before and after the operation, glycoprotein
and MUC5AC measurements were significantly higher in
patients with respiratory complications than in those with-
out (glycoprotein: pre P  .0001, post P  .0001, 4 h P 
.0004, 24 h P  .0012; MUC5AC: pre P  .0002, post P 
.0001, 4 h P  .0001, 24 h P  .021; Figure 1, A and B).
MUC5B concentration was also higher in patients with
respiratory complications after CPB (P  .012 immediately
after CPB, P  .0002 at 4 hours, and P  .003 at 24 hours
after CPB (Figure 1, C).
None of the following preoperative or intraoperative
factors were significantly associated with airway lavage
fluid mucin concentration: age, body weight, aortic cross-
clamp and CPB times, circulatory arrest duration, lowest
rectal temperature, and hemoglobin concentration during
CPB (r 0.2 and P .2). Only CPB duration had a weakly
positive correlation with MUC5AC concentration immedi-
ately after CPB (r  0.31, P  .05). There were no signif-
icant differences between children with and without respi-
ratory complications in these variables.
Patients with respiratory complications also had a greater
proportion of MUC5AC before and up to 4 hours after
operation than did patients without respiratory complica-
tions (before P .008, after P .0002, 4 h P .01; Figure
2).
Mucin Increase and Grade of Respiratory
Complications
Although there were relatively few subjects in each cate-
gory of respiratory complication, patients with grade 2 and
Figure 1. Time-dependent changes in glycoprotein (A), MUC5AC (B), MUC5B (C), and MUC2 (D) in patients with
(dotted boxes) and without (open boxes) respiratory complications before (Pre-Op) and after CPB. Boxes represent
interquartile range (25-75 percentile); line within each box represents median. Bars show 10th and 90th percen-
tiles. Dagger indicates P < .05 versus group without respiratory complications; asterisk indicates P < .05 versus
preoperative value.
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3 respiratory complications showed a significantly greater
increase in total mucin during CPB than did patients with
grade 0 (grade 2, P  .002; grade 3, P  .01). Furthermore,
the increase of total mucin in grade 3 tended to be higher
than that in grade 1 (P  .10). There was a significant
correlation between the increase of total mucin during CPB
and the grade of respiratory complication (r  0.70, P 
.01; Figure 3). Total mucin at 4 hours after CPB still showed
significant correlation with the grade of respiratory compli-
cations (data not shown).
Relationship Between Mucin Increase and Lung
Injury
Airway lavage fluid DNA content significantly increased
during CPB (4.3 ng/g protein, interquartile range 1.9-7.3
ng/g protein, to 18.1 ng/g protein, interquartile range
6.3-38.4 ng/g protein, P  .0001), and the increase of
DNA during CPB showed a positive correlation with the
duration of CPB (P  .004) and increase of total mucin
during CPB (P  .0001, Figure 4, A). PAO2  PaO2
increased after CPB (240.2 mm Hg, interquartile range
126.1-282.2 mm Hg, to 402.4 mm Hg, interquartile range
370.0-510.7 mm Hg, P  .0001), and there was a positive
correlation between PAO2  PaO2 immediately after CPB
and the increase of total mucin during CPB (P  .0007;
Figure 4, B). PaCO2 also increased after CPB (32.0 mm
Hg, interquartile range 28.6-36.4 mm Hg, to 37.8 mm Hg,
interquartile range 32.9-42.1 mm Hg, P  .0001), and
there was a positive correlation between PaCO2 immedi-
ately after CPB and an increase of total mucin during
CPB (P  .0001; Figure 4, C).
Mucin Changes During Operations Without CPB
There were no significant changes in glycoprotein concen-
tration (0.50 g/g protein, interquartile range 0.34-0.82
g/g protein, to 0.70 g/g protein, interquartile range
g/g protein, interquartile range 0.54-0.81 g/g protein),
any mucin components (MUC5AC 0.31 g/g protein,
interquartile range 0.08-0.56 g/g protein, to 0.25 g/g
protein, interquartile range 0.10-0.53 g/g protein;
MUC5B 0.04 g/g protein, interquartile range 0.02-0.09
g/g protein, to 0.05 g/g protein, interquartile range
0.02-0.10 g/g protein; MUC2 0.01 g/g protein, inter-
quartile range 0.004-0.022 g/g protein, to 0.04 g/g
protein, interquartile range 0.008-0.061 g/g protein), and
DNA level (4.1 ng/g protein, interquartile range 2.7-7.3
ng/g protein, to 5.0 ng/g protein, interquartile range
2.1-10.1 ng/g protein) in airway lavage fluid during oper-
ation without CPB. Three children had atelectasis of the
lungs on the side of thoracotomy after operation. Although
MUC5AC and MUC5B levels were slightly higher in pa-
tients with respiratory complications after operation
(MUC5AC 0.30 g/g protein, interquartile range 0.09-
0.39 g/g protein, vs 1.66 g/g protein, interquartile
range 0.50-2.16 g/g protein; MUC5B 0.05 g/g pro-
tein, interquartile range 0.03-0.07 g/g protein, vs 0.10
g/g protein, interquartile range 0.09-0.19 g/g protein),
the numbers of subjects were too small to allow meaningful
statistical comparisons.
Discussion
To our knowledge, this is the first study to demonstrate that
increases in respiratory mucins in airway lavage fluid are
Figure 2. Time-dependent change in ratio of MUC5AC to total
mucins in patients with (dotted boxes) and without (open boxes)
respiratory complications before (Pre-Op) and after CPB. Boxes
represent interquartile range (25th to 75th percentile); line within
each box represents median. Bars show 10th and 90th percen-
tiles. Dagger indicates P < .05 versus group without respiratory
complications.
Figure 3. Relationship between grade of respiratory complication
(see text for definitions) and increase in total mucin during CPB
(grade 0, n  25; grade 1, n  3; grade 2, n  7; grade 3, n  4).
Boxes represent interquartile range (25th to 75th percentile); line
within each box represents median. Bars show 10th and 90th
percentiles. Asterisk indicates P < .01 versus grade 0.
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associated with respiratory complications after CPB. Respi-
ratory complications are common sequelae of cardiac sur-
gery in infants and young children. We observed respiratory
complications in 34% of our patients in this study, including
pneumonia in 10.4%, and these incidences were similar to
those in previous reports. Previous studies have demon-
strated that increased mucin concentration is associated with
airway obstruction, gas exchange abnormalities, and bacte-
rial infections of the lungs15,16. These observations are
consistent with our results, which demonstrate an associa-
tion between increased mucin concentration and increased
PAO2  PaO2 gradient.
There are several possible explanations for our observa-
tions. An increase in mucin could result from increased
synthesis, increased secretion of stored mucin, decreased
mucin clearance, or cell destruction with release of cell
contents into the airway lumen. The relationship between
increases of mucins and DNA during CPB in our results
may reflect cell injury with passive leakage of stored mucin
from damaged epithelial cells. However, active secretion in
response to pulmonary inflammation associated with CPB
appears to be the most likely explanation, although specific
mechanisms were not identified in this study.
Support for a direct relationship between the degree of
acute lung injury and increased mucin production or secre-
tion has been reported.17 CPB is known to cause an acute
inflammatory response in the lungs, with marked increases
in several proinflammatory cytokines and in neutrophil elas-
tase,18 and these may be responsible for direct cytokine- or
neutrophil elastase–mediated stimulation of mucin produc-
tion.19,20 In vitro studies have shown increased production
of mucin in association with interleukin 919 and interleukin
13, and neutrophil elastase is associated with damage to
cilia, reduction in ciliary function,20 increased mucin pro-
duction,21 and upregulation of mucin gene expression.22
The greater proportion of MUC5AC that was observed in
patients with respiratory complications implicates a muco-
sal surface event in these subjects, because MUC5AC is
located in the superficial epithelium and MUC5B is located
in the submucosal glands.5,13 This specific change in mucin
composition suggests that our observations are not simply
the result of a generalized pulmonary insult, with passive
release of mucin from disrupted epithelial cells. The rela-
tionships between risk factors for lung injury, including
CPB time and increased DNA and total mucin contents,
suggest that the increased airway mucin concentrations are
related to an inflammatory lung injury.
One potentially important finding of our study is the
observation that patients who had postoperative respiratory
complications had a higher proportion of MUC5AC in the
preoperative airway lavage sample. This may imply that
these children had subclinical infections before the opera-
Figure 4. Relationship between increase in total mucin and physiologic indicators of lung injury: DNA in airway
lavage fluid (A), alveolar arterial oxygen difference (A-aO2; B), and PaCO2 (C).
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tion and were therefore predisposed toward respiratory
complications. Alternatively, if these children had high con-
stitutive expression of MUC5AC that predisposed them
toward respiratory complications, this measurement may
have a place as a predictive factor for pulmonary compli-
cations of cardiac surgery in children and deserves further
evaluation.
The findings in subjects who had operations without
CPB implicate CPB as the major factor in determining
postoperative mucin responses, rather than the operative
procedure itself. Three children had respiratory complica-
tions without significant increase of mucin after operation
without CPB. This may be explained by the difference in
mechanisms of respiratory complications between opera-
tions with and without CPB or median sternotomy and
thoracotomy. Our observation that all the respiratory com-
plications in children without CPB were atelectasis seen on
the same side as the thoracotomy may indicate the direct
influence of surgical procedure on the lungs. Further inves-
tigations are necessary to elucidate the details of these
mechanisms.
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